CR20200645A - Derivado policiclíco de piridona - Google Patents
Derivado policiclíco de piridonaInfo
- Publication number
- CR20200645A CR20200645A CR20200645A CR20200645A CR20200645A CR 20200645 A CR20200645 A CR 20200645A CR 20200645 A CR20200645 A CR 20200645A CR 20200645 A CR20200645 A CR 20200645A CR 20200645 A CR20200645 A CR 20200645A
- Authority
- CR
- Costa Rica
- Prior art keywords
- sup
- substituted
- pyridone derivative
- ring
- polycyclic pyridone
- Prior art date
Links
- -1 Polycyclic pyridone derivative Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
<p>La presente invención se relaciona con un compuesto representado por la siguiente fórmula (I) (en la fórmula, el anillo A es un heterociclo no aromático sustituido o no sustituido; el anillo C es un anillo de benceno, etc.; Q es un heterociclo aromático de 5 miembros, etc.; R1 es independientemente halógeno, etc.; L es alquileno sustituido o no sustituido; R<sup>3</sup> es alquilo sustituido o no sustituido, etc.; R<sup>4</sup> es hidrógeno, etc.; y n es un número entero de 1 a 3</p>
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018104160 | 2018-05-31 | ||
| PCT/JP2019/021445 WO2019230857A1 (ja) | 2018-05-31 | 2019-05-30 | 多環性ピリドン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20200645A true CR20200645A (es) | 2021-02-05 |
Family
ID=68698906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20200645A CR20200645A (es) | 2018-05-31 | 2019-05-30 | Derivado policiclíco de piridona |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US11453669B2 (es) |
| EP (1) | EP3805221A4 (es) |
| JP (1) | JP7353707B2 (es) |
| KR (1) | KR102770090B1 (es) |
| CN (1) | CN112533922B (es) |
| AU (1) | AU2019277547B2 (es) |
| BR (1) | BR112020024098A2 (es) |
| CA (1) | CA3101950A1 (es) |
| CL (1) | CL2020002987A1 (es) |
| CO (1) | CO2020014296A2 (es) |
| CR (1) | CR20200645A (es) |
| DO (1) | DOP2020000222A (es) |
| EA (1) | EA202092923A1 (es) |
| IL (1) | IL279050B2 (es) |
| MA (1) | MA52802A (es) |
| MX (1) | MX2020012185A (es) |
| MY (1) | MY203593A (es) |
| PE (1) | PE20201414A1 (es) |
| PH (1) | PH12020551999A1 (es) |
| SG (1) | SG11202011386QA (es) |
| WO (1) | WO2019230857A1 (es) |
| ZA (1) | ZA202007568B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS65891B1 (sr) | 2018-05-31 | 2024-09-30 | Shionogi & Co | Policiklični karbamoilpiridonski derivati za lečenje hiv-a |
| LT3938047T (lt) | 2019-03-22 | 2022-10-10 | Gilead Sciences, Inc. | Tilteliniai tricikliniai karbamoilpiridono junginiai ir jų naudojimas farmacijoje |
| JP2021091671A (ja) * | 2019-11-28 | 2021-06-17 | 塩野義製薬株式会社 | 多環性ピリドン誘導体を含有する医薬組成物 |
| TWI902729B (zh) * | 2019-11-28 | 2025-11-01 | 日商鹽野義製藥股份有限公司 | 以組合整合酶阻礙劑及抗ｈｉｖ藥為特徵之ｈｉｖ感染症的預防及治療用醫藥 |
| WO2021107065A1 (ja) * | 2019-11-28 | 2021-06-03 | 塩野義製薬株式会社 | 多環性ピリドピラジン誘導体 |
| BR112022015771A2 (pt) | 2020-02-24 | 2022-10-11 | Gilead Sciences Inc | Compostos tetracíclicos para tratar a infecção por hiv |
| US12516070B2 (en) | 2020-05-21 | 2026-01-06 | Cisen Pharmaceutical Co., Ltd | Fused ring derivatives and use thereof in pharmacy |
| JP7695339B2 (ja) * | 2020-07-27 | 2025-06-18 | メルク・シャープ・アンド・ドーム・エルエルシー | インフルエンザを治療又は予防するための多環式キャップ依存性エンドヌクレアーゼ阻害薬 |
| TW202222798A (zh) | 2020-09-30 | 2022-06-16 | 美商基利科學股份有限公司 | 橋接三環胺甲醯基吡啶酮化合物及其用途 |
| PT4196479T (pt) | 2021-01-19 | 2024-01-03 | Gilead Sciences Inc | Compostos de piridotriazinas substituídos e suas utilizações |
| US20250230161A1 (en) * | 2021-08-11 | 2025-07-17 | Merck Sharp & Dohme Llc | Polycyclic cap-dependent endonuclease inhibitors for treating or preventing influenza |
| TWI856796B (zh) | 2022-04-06 | 2024-09-21 | 美商基利科學股份有限公司 | 橋聯三環胺甲醯基吡啶酮化合物及其用途 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1549315A4 (en) | 2002-09-11 | 2007-05-23 | Merck & Co Inc | DIHYDROXYPYRIDOPYRAZINE-1,6-DION COMPOUNDS AS HIV INTEGRASE INHIBITORS |
| MXPA05007010A (es) | 2002-12-27 | 2005-08-18 | Angeletti P Ist Richerche Bio | Tetrahidro-4h-pirido[1,2-a]pirimidinas y compuestos relacionados utiles como inhibidores de la integrasa del virus de inmunodeficiencia humana. |
| TW200510425A (en) | 2003-08-13 | 2005-03-16 | Japan Tobacco Inc | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
| ATE516026T1 (de) | 2005-02-21 | 2011-07-15 | Shionogi & Co | Bicyclisches carbamoylpyridonderivat mit hiv- integrase-hemmender wirkung |
| DK1874117T3 (da) * | 2005-04-28 | 2013-09-23 | Viiv Healthcare Co | Polycyklisk carbamoylpyridonderivat med hiv-integrasehæmmende aktivitet |
| JP5131689B2 (ja) * | 2005-10-27 | 2013-01-30 | 塩野義製薬株式会社 | Ｈｉｖインテグラーゼ阻害活性を有する多環性カルバモイルピリドン誘導体 |
| US10065950B2 (en) | 2010-02-26 | 2018-09-04 | Japan Tobacco Inc. | Substituted thiazoles as HIV integrase inhibitors |
| US9216995B2 (en) | 2010-04-12 | 2015-12-22 | Shionogi & Co., Ltd. | Pyridone derivative having integrase inhibitory activity |
| AU2012321762A1 (en) | 2011-10-12 | 2014-04-17 | Shionogi & Co., Ltd. | Polycyclic pyridone derivative having integrase-inhibiting activity |
| WO2014099586A1 (en) * | 2012-12-17 | 2014-06-26 | Merck Sharp & Dohme Corp. | 4-pyridinonetriazine derivatives as hiv integrase inhibitors |
| SI2822954T1 (sl) | 2012-12-21 | 2016-07-29 | Gilead Sciences, Inc. | Policiklične karbamoilpiridonske spojine in njihova farmacevtska uporaba |
| EP2940019B1 (en) | 2012-12-27 | 2018-03-28 | Japan Tobacco Inc. | SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND MEDICINAL USE THEREOF AS HIV INTEGRASE INHIBITOR |
| HUE036384T2 (hu) | 2013-05-17 | 2018-07-30 | Merck Sharp & Dohme | Fúzionált triciklusos heterociklikus vegyületek mint HIV integráz inhibitorok |
| EP3008044B1 (en) * | 2013-06-13 | 2018-11-21 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors |
| WO2014200080A1 (ja) | 2013-06-14 | 2014-12-18 | ヤンマー株式会社 | 予測装置、予測方法及びコンピュータプログラム |
| PT3019503T (pt) | 2013-07-12 | 2017-11-27 | Gilead Sciences Inc | Compostos carbamoílpiridona- policíclicos e seu uso para o tratamento de infecções por hiv |
| NO2865735T3 (es) | 2013-07-12 | 2018-07-21 | ||
| WO2015039348A1 (en) | 2013-09-23 | 2015-03-26 | Merck Sharp & Dohme Corp. | Tetracyclic heterocycle compounds useful as hiv integrase inhibitors |
| AU2014324829B2 (en) | 2013-09-27 | 2017-09-07 | Merck Sharp & Dohme Corp. | Substituted Quinolizine Derivatives useful as HIV integrase inhibitors |
| WO2015089847A1 (en) | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | Spirocyclic heterocycle compounds useful as hiv integrase inhibitors |
| WO2015199167A1 (ja) | 2014-06-25 | 2015-12-30 | 日本たばこ産業株式会社 | 置換されたスピロピリド［１，２－ａ］ピラジン誘導体の製造方法および中間体 |
| WO2016027879A1 (ja) | 2014-08-22 | 2016-02-25 | 塩野義製薬株式会社 | インテグラーゼ阻害活性を有する多環性ピリドン誘導体 |
| EP3229804B1 (en) | 2014-12-09 | 2020-05-06 | Merck Sharp & Dohme Corp. | Spirocyclic heterocycle compounds useful as hiv integrase inhibitors |
| WO2016090545A1 (en) | 2014-12-09 | 2016-06-16 | Merck Sharp & Dohme Corp. | Spirocyclic heterocycle compounds useful as hiv integrate inhibitors |
| TWI695003B (zh) | 2014-12-23 | 2020-06-01 | 美商基利科學股份有限公司 | 多環胺甲醯基吡啶酮化合物及其醫藥用途 |
| US10081647B2 (en) | 2015-03-26 | 2018-09-25 | Merck Sharp & Dohme Corp. | Phosphate substituted quinolizine derivatives useful as HIV integrase inhibitors |
| WO2016161382A1 (en) | 2015-04-02 | 2016-10-06 | Gilead Sciences, Inc. | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use |
| WO2016187788A1 (en) | 2015-05-25 | 2016-12-01 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds useful for treating hiv infection |
| EP3377066B1 (en) | 2015-11-17 | 2021-04-07 | Merck Sharp & Dohme Corp. | Amido-substituted pyridotriazine derivatives useful as hiv integrase inhibitors |
| WO2017087256A1 (en) | 2015-11-17 | 2017-05-26 | Merck Sharp & Dohme Corp. | Spirocyclic pyridotriazine derivatives useful as hiv integrase inhibitors |
| US10544155B2 (en) | 2015-12-15 | 2020-01-28 | Merck Sharp & Dohme Corp. | Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors |
| WO2017113288A1 (en) | 2015-12-31 | 2017-07-06 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors |
| JOP20190130A1 (ar) | 2016-12-02 | 2019-06-02 | Merck Sharp & Dohme | مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv) |
| MX384729B (es) | 2016-12-02 | 2025-03-14 | Merck Sharp & Dohme | Compuestos heterocíclicos tricíclicos útiles como inhibidores de la integrasa del virus de inmunodeficiencia humana (vih). |
| WO2019160783A1 (en) | 2018-02-15 | 2019-08-22 | Merck Sharp & Dohme Corp. | Tricyclic heterocycle compounds useful as hiv integrase inhibitors |
| MA52367A (fr) | 2018-04-27 | 2021-03-03 | Merck Sharp & Dohme | Composés hétérocycliques tricycliques utiles en tant qu'inhibiteurs de l'intégrase du vih |
| CN110526930B (zh) | 2018-05-23 | 2022-06-03 | 莫云芬 | 抗hiv病毒的含硫多环-羟基吡啶酮甲酰胺类似物及其应用 |
| US11884683B2 (en) | 2018-06-05 | 2024-01-30 | Merck Sharp & Dohme Llc | Tricyclic heterocycle compounds useful as HIV integrase inhibitors |
| LT3938047T (lt) | 2019-03-22 | 2022-10-10 | Gilead Sciences, Inc. | Tilteliniai tricikliniai karbamoilpiridono junginiai ir jų naudojimas farmacijoje |
-
2019
- 2019-05-30 PE PE2020001864A patent/PE20201414A1/es unknown
- 2019-05-30 BR BR112020024098-2A patent/BR112020024098A2/pt active Search and Examination
- 2019-05-30 KR KR1020207037581A patent/KR102770090B1/ko active Active
- 2019-05-30 EA EA202092923A patent/EA202092923A1/ru unknown
- 2019-05-30 JP JP2020522576A patent/JP7353707B2/ja active Active
- 2019-05-30 AU AU2019277547A patent/AU2019277547B2/en active Active
- 2019-05-30 MY MYPI2020006047A patent/MY203593A/en unknown
- 2019-05-30 CN CN201980050400.4A patent/CN112533922B/zh active Active
- 2019-05-30 WO PCT/JP2019/021445 patent/WO2019230857A1/ja not_active Ceased
- 2019-05-30 CA CA3101950A patent/CA3101950A1/en active Pending
- 2019-05-30 IL IL279050A patent/IL279050B2/en unknown
- 2019-05-30 SG SG11202011386QA patent/SG11202011386QA/en unknown
- 2019-05-30 MA MA052802A patent/MA52802A/fr unknown
- 2019-05-30 US US17/058,260 patent/US11453669B2/en active Active
- 2019-05-30 EP EP19812190.7A patent/EP3805221A4/en active Pending
- 2019-05-30 MX MX2020012185A patent/MX2020012185A/es unknown
- 2019-05-30 CR CR20200645A patent/CR20200645A/es unknown
-
2020
- 2020-11-17 CL CL2020002987A patent/CL2020002987A1/es unknown
- 2020-11-18 CO CONC2020/0014296A patent/CO2020014296A2/es unknown
- 2020-11-20 PH PH12020551999A patent/PH12020551999A1/en unknown
- 2020-11-27 DO DO2020000222A patent/DOP2020000222A/es unknown
- 2020-12-04 ZA ZA2020/07568A patent/ZA202007568B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102770090B1 (ko) | 2025-02-18 |
| BR112020024098A2 (pt) | 2021-02-17 |
| MX2020012185A (es) | 2021-01-29 |
| MA52802A (fr) | 2021-04-14 |
| PE20201414A1 (es) | 2020-12-07 |
| ZA202007568B (en) | 2022-04-28 |
| WO2019230857A1 (ja) | 2019-12-05 |
| CN112533922A (zh) | 2021-03-19 |
| MY203593A (en) | 2024-07-05 |
| AU2019277547B2 (en) | 2024-10-10 |
| SG11202011386QA (en) | 2020-12-30 |
| US11453669B2 (en) | 2022-09-27 |
| AU2019277547A1 (en) | 2021-01-14 |
| PH12020551999A1 (en) | 2021-09-27 |
| IL279050B2 (en) | 2024-12-01 |
| CN112533922B (zh) | 2024-03-22 |
| US20210155622A1 (en) | 2021-05-27 |
| CL2020002987A1 (es) | 2021-04-16 |
| CA3101950A1 (en) | 2019-12-05 |
| KR20210018324A (ko) | 2021-02-17 |
| EA202092923A1 (ru) | 2021-04-09 |
| CO2020014296A2 (es) | 2020-12-21 |
| IL279050A (en) | 2021-01-31 |
| EP3805221A4 (en) | 2022-01-05 |
| DOP2020000222A (es) | 2021-03-15 |
| EP3805221A1 (en) | 2021-04-14 |
| IL279050B1 (en) | 2024-08-01 |
| JPWO2019230857A1 (ja) | 2021-06-24 |
| JP7353707B2 (ja) | 2023-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20200645A (es) | Derivado policiclíco de piridona | |
| PH12020552000A1 (en) | Polycyclic carbamoylpyridone derivative | |
| MX2021000795A (es) | Compuestos heterociclicos para inhibir la actividad de shp2. | |
| MX2020014116A (es) | Agente profilactico o terapeutico para atrofia muscular espinal. | |
| MX385402B (es) | Derivados de piridona policiclica sustituida y profarmaco de los mismos. | |
| MX384474B (es) | Derivado de anillo fusionado de 9 elementos. | |
| ATE331304T1 (de) | Halbleiter auf basis von substituiertem pentacen | |
| JOP20180011A1 (ar) | مشتقات بيرولو [1، 2-b]بيريدازين | |
| MX2010001170A (es) | Derivados de imidazolona, metodo de preparacion de los mismos y uso biologico de los mismos. | |
| MY202326A (en) | Compound having cyclic structure | |
| AR115007A1 (es) | Derivados de triazolona o sales de los mismos y composiciones farmacéuticas que comprenden los mismos | |
| AR115006A1 (es) | Derivados de aril o heteroaril triazolona o sales de los mismos o composiciones farmacéuticas que comprenden los mismos | |
| MX2020012760A (es) | Nuevos compuestos de piridina y pirazina como inhibidores del receptor cannabinoide 2. | |
| CR20240289A (es) | Nuevos derivados de benzimidazol piridina | |
| TW201613933A (en) | Long acting HIV protease inhibitor | |
| DOP2022000073A (es) | Derivados de 2-azaspiro[3,4]octano como agonistas de m4 | |
| WO2021058754A8 (en) | Pharmaceutical compounds | |
| SG11201811541TA (en) | Composition for removing iron sulfide | |
| SA520420914B1 (ar) | مشتق حلقي عطري غير متجانس ثنائي الحلقة | |
| MX2013012457A (es) | Derivados heteroaromaticos de anillo de 5 miembros que tienen actividad antagonista del receptor y5 de neuropeptido (npy). | |
| TW200624411A (en) | Organic electrically functional material and electroninc device using the same | |
| MX2020011382A (es) | Derivados de tetrahidropiranoxazina que tienen actividad inhibidora de beta-secretasa 1 (bace1) selectiva. | |
| ES283103A1 (es) | Procedimiento para preparar nuevos derivados de piridonas hidrogenadas | |
| ATE529410T1 (de) | Anthrapyridonverbindungen | |
| ES357925A1 (es) | Procedimiento para la preparacion de colorantes azoicos in-solubles en agua. |